These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 22653557)

  • 21. Alteration of the cytokine phenotype in an experimental lung granuloma model by inhibiting nitric oxide.
    Hogaboam CM; Chensue SW; Steinhauser ML; Huffnagle GB; Lukacs NW; Strieter RM; Kunkel SL
    J Immunol; 1997 Dec; 159(11):5585-93. PubMed ID: 9548500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic blockade of nitric oxide synthesis reduces adiposity and improves insulin resistance in high fat-induced obese mice.
    Tsuchiya K; Sakai H; Suzuki N; Iwashima F; Yoshimoto T; Shichiri M; Hirata Y
    Endocrinology; 2007 Oct; 148(10):4548-56. PubMed ID: 17584959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence that nitric oxide inhibits vascular inflammation and superoxide production via a p47phox-dependent mechanism in mice.
    Harrison CB; Drummond GR; Sobey CG; Selemidis S
    Clin Exp Pharmacol Physiol; 2010 Apr; 37(4):429-34. PubMed ID: 19843095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic (-)-epicatechin improves vascular oxidative and inflammatory status but not hypertension in chronic nitric oxide-deficient rats.
    Gómez-Guzmán M; Jiménez R; Sánchez M; Romero M; O'Valle F; Lopez-Sepulveda R; Quintela AM; Galindo P; Zarzuelo MJ; Bailón E; Delpón E; Perez-Vizcaino F; Duarte J
    Br J Nutr; 2011 Nov; 106(9):1337-48. PubMed ID: 21910946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiomyocyte mineralocorticoid receptors are essential for deoxycorticosterone/salt-mediated inflammation and cardiac fibrosis.
    Rickard AJ; Morgan J; Bienvenu LA; Fletcher EK; Cranston GA; Shen JZ; Reichelt ME; Delbridge LM; Young MJ
    Hypertension; 2012 Dec; 60(6):1443-50. PubMed ID: 23108646
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mineralocorticoid Receptor Deficiency in Macrophages Inhibits Atherosclerosis by Affecting Foam Cell Formation and Efferocytosis.
    Shen ZX; Chen XQ; Sun XN; Sun JY; Zhang WC; Zheng XJ; Zhang YY; Shi HJ; Zhang JW; Li C; Wang J; Liu X; Duan SZ
    J Biol Chem; 2017 Jan; 292(3):925-935. PubMed ID: 27881672
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cross-talk between mineralocorticoid receptor/angiotensin II type 1 receptor and mitogen-activated protein kinase pathways underlies aldosterone-induced atrial fibrotic responses in HL-1 cardiomyocytes.
    Tsai CF; Yang SF; Chu HJ; Ueng KC
    Int J Cardiol; 2013 Oct; 169(1):17-28. PubMed ID: 24120080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of endothelial nitric oxide synthase induces and enhances myocardial fibrosis.
    Kazakov A; Hall R; Jagoda P; Bachelier K; Müller-Best P; Semenov A; Lammert F; Böhm M; Laufs U
    Cardiovasc Res; 2013 Nov; 100(2):211-21. PubMed ID: 23863197
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Valsartan improves L-NAME-exacerbated cardiac fibrosis with TGF-ß inhibition and apoptosis induction in spontaneously hypertensive rats.
    Akashiba A; Ono H; Ono Y; Ishimitsu T; Matsuoka H
    J Cardiol; 2008 Dec; 52(3):239-46. PubMed ID: 19027602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myeloid mineralocorticoid receptor controls macrophage polarization and cardiovascular hypertrophy and remodeling in mice.
    Usher MG; Duan SZ; Ivaschenko CY; Frieler RA; Berger S; Schütz G; Lumeng CN; Mortensen RM
    J Clin Invest; 2010 Sep; 120(9):3350-64. PubMed ID: 20697155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aldosterone deficiency and mineralocorticoid receptor antagonism prevent angiotensin II-induced cardiac, renal, and vascular injury.
    Luther JM; Luo P; Wang Z; Cohen SE; Kim HS; Fogo AB; Brown NJ
    Kidney Int; 2012 Sep; 82(6):643-51. PubMed ID: 22622494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aberrant Rac1-mineralocorticoid receptor pathways in salt-sensitive hypertension.
    Kawarazaki W; Fujita T
    Clin Exp Pharmacol Physiol; 2013 Dec; 40(12):929-36. PubMed ID: 24111570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aldosterone inhibits antifibrotic factors in mouse hypertensive heart.
    Azibani F; Benard L; Schlossarek S; Merval R; Tournoux F; Fazal L; Polidano E; Launay JM; Carrier L; Chatziantoniou C; Samuel JL; Delcayre C
    Hypertension; 2012 Jun; 59(6):1179-87. PubMed ID: 22547442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aldosterone mediates angiotensin II-induced interstitial cardiac fibrosis via a Nox2-containing NADPH oxidase.
    Johar S; Cave AC; Narayanapanicker A; Grieve DJ; Shah AM
    FASEB J; 2006 Jul; 20(9):1546-8. PubMed ID: 16720735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiac Tissue Injury and Remodeling Is Dependent Upon MR Regulation of Activation Pathways in Cardiac Tissue Macrophages.
    Shen JZ; Morgan J; Tesch GH; Rickard AJ; Chrissobolis S; Drummond GR; Fuller PJ; Young MJ
    Endocrinology; 2016 Aug; 157(8):3213-23. PubMed ID: 27253999
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of aldosterone in angiotensin II-induced cardiac and aortic inflammation, fibrosis, and hypertrophy.
    Neves MF; Amiri F; Virdis A; Diep QN; Schiffrin EL;
    Can J Physiol Pharmacol; 2005 Nov; 83(11):999-1006. PubMed ID: 16391708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heart remodeling in the hereditary hypertriglyceridemic rat: effect of captopril and nitric oxide deficiency.
    Simko F; Luptak I; Matuskova J; Babal P; Pechanova O; Bernatova I; Hulin I
    Ann N Y Acad Sci; 2002 Jun; 967():454-62. PubMed ID: 12079874
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiotensin II type 1 receptor blocker prevents atrial structural remodeling in rats with hypertension induced by chronic nitric oxide inhibition.
    Okazaki H; Minamino T; Tsukamoto O; Kim J; Okada K; Myoishi M; Wakeno M; Takashima S; Mochizuki N; Kitakaze M
    Hypertens Res; 2006 Apr; 29(4):277-84. PubMed ID: 16778335
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Osteopontin deficiency protects against aldosterone-induced inflammation, oxidative stress, and interstitial fibrosis in the kidney.
    Irita J; Okura T; Jotoku M; Nagao T; Enomoto D; Kurata M; Desilva VR; Miyoshi K; Matsui Y; Uede T; Denhardt DT; Rittiling SR; Higaki J
    Am J Physiol Renal Physiol; 2011 Oct; 301(4):F833-44. PubMed ID: 21734100
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nitric oxide inhibition induces early activation of type I collagen gene in renal resistance vessels and glomeruli in transgenic mice. Role of endothelin.
    Chatziantoniou C; Boffa JJ; Ardaillou R; Dussaule JC
    J Clin Invest; 1998 Jun; 101(12):2780-9. PubMed ID: 9637712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.